Medical contrast agent is a material used in medical imaging to improve the contrast of structure or fluids inside a body. The contrast agents provide enhanced visibility for observation of blood vessels and the gastrointestinal tract. According to the imaging modalities such as x-ray and ultrasound, an array of contrast reagents is used as per requirement of the imaging technique.

Market Analysis and Insights: Global Medical Contrast Agent Market
The global Medical Contrast Agent market was valued at US$ XX in 2020 and will reach US$ XX million by the end of 2027, growing at a CAGR of XX% during 2022-2027.

Global Medical Contrast Agent Scope and Market Size
The global Medical Contrast Agent market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Medical Contrast Agent market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by region (country), by Type and by Application for the period 2016-2027.

Segment by Type
Barium-based Contrast Media
Iodinated Contrast Media
Gadolinium-based Contrast Media
Microbubble Contrast Media

Segment by Application
Cardiovascular Disorders
Neurological Disorders
Gastrointestinal Disorders
Cancer
Nephrological Disorders
Musculoskeletal Disorders
Other Applications

The Medical Contrast Agent market is analysed and market size information is provided by regions (countries). Segment by Application, the Medical Contrast Agent market is segmented into North America, Europe, China, Japan, Southeast Asia, India and Other Regions.

By Company
GE Healthcare
Bayer
Bracco Imaging
Guerbet Group
Lantheus Medical Imaging
Nanopet Pharma
CMC Contrast
Daiichi Sankyo
Subhra Pharma Private
Spago Nanomedical